Search Results

Bisphosphonates/various other drugs: Low-energy femoral fractures: 8 case reports

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 11-12(2)

Publisher: Adis International

The effects of tibolone on the human primary glioblastoma multiforme cell culture and the rat C6 glioma model

Authors: Altınoz, Meric A.; Albayrak, Serdar Baki; Karasu, Aykut; Sabanci, Pulat Akin; Imer, Murat; Bilir, Ayhan

Source: Neurological Research, Volume 31, Number 9, November 2009 , pp. 923-927(5)

Publisher: Maney Publishing

Tibolone: Endometrial hyperplasia: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 28-28(1)

Publisher: Adis International

Although tamoxifen, raloxifene and tibolone significantly reduce the risk of breast cancer, the use of each drug is associated with distinct adverse effects

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 3-3(1)

Publisher: Adis International

Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain

Authors: Al-Azemi, M; Jones, G; Sirkeci, F; Walters, S; Houdmont, M; Ledger, W

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 116, Number 12, November 2009 , pp. 1646-1656(11)

Publisher: Blackwell Publishing

Interactions Between Herbal Medicines and Prescribed Drugs: An Updated Systematic Review

Authors: Izzo, Angelo A.; Ernst, Edzard

Source: Drugs, Volume 69, Number 13, 10 September 2009 , pp. 1777-1798(22)

Publisher: Adis International

Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO₂, and their nanocomposites as appropriate drug carriers

Authors: Papadimitriou, Sofia; Bikiaris, Dimitrios

Source: Drug Development and Industrial Pharmacy, Volume 35, Number 9, September 2009 , pp. 1128-1138(11)

Publisher: Informa Healthcare

Complex endometrial hyperplasia in the context of tibolone administration

Authors: KANE, Stefan C.; QUINN, Michael A.

Source: Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 49, Number 3, June 2009 , pp. 338-339(2)

Publisher: Blackwell Publishing

Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of the OPAL study*

Authors: Dogan, S.; Plantinga, Y.; Evans, G. W.; Meijer, R.; Grobbee, D. E.; Bots, M. L.

Source: Current Medical Research and Opinion, Volume 25, Number 1, January 2009 , pp. 109-122(14)

Publisher: Informa Healthcare

Tibolone: First report of bullous pemphigoid: case report

Source: Reactions, Volume 1, Number 1246, 2009-04-04 , pp. 32-32(1)

Publisher: Adis International

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction

Authors: Nijland, E. A.; Nathorst-Boos, J.; Palacios, S.; van de Weijer, P. W.; Davis, S.; Stathopoulos, V. M.; Birkhaeuser, M. H.; von Mauw, E.; Mulder, R. J.; Weijmar Schultz for the LISA study investigators group, W.C. M.

Source: Climacteric, Volume 12, Number 2, April 2009 , pp. 114-121(8)

Publisher: Informa Healthcare

Testosterone replacement therapy in the climacteric: Benefits beyond sexuality

Authors: Maia, Hugo; Casoy, Julio; Valente, Jorge

Source: Gynecological Endocrinology, Volume 25, Number 1, January 2009 , pp. 12-20(9)

Publisher: Informa Healthcare

The Use of Estrogen Therapy in Women's Sexual Functioning (CME)

Authors: Nappi, Rossella E.; Polatti, Franco

Source: The Journal of Sexual Medicine, Volume 6, Number 3, March 2009 , pp. 603-616(14)

Publisher: Blackwell Publishing

Short-term effect of tibolone on C-reactive protein in hypertensive postmenopausal women

Authors: Engin-Üstün, Yaprak; Üstün, Yusuf; Türkçüoğlu, Ilgın; Mutlu Meydanlı, M.; Kafkaslı, Ayşe; Yetkin, Gülay

Source: Archives of Gynecology and Obstetrics, Volume 279, Number 3, March 2009 , pp. 305-309(5)

Publisher: Springer

Estrogen Sulfotransferases in Breast and Endometrial Cancers

Author: Pasqualini, Jorge Raul

Source: Annals of the New York Academy of Sciences, Volume 1155, Number 1, February 2009 , pp. 88-98(11)

Publisher: Blackwell Publishing

Hormone therapy and risk of myocardial infarction

Author: Lowe, Gordon

Source: Women's Health, Volume 5, Number 1, January 2009 , pp. 29-31(3)

Publisher: Future Medicine

New findings with old drugs for osteoporosis

Author: Doggrell, Sheila A

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 3, February 2009 , pp. 513-516(4)

Publisher: Informa Healthcare

The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-α and hepatocyte growth factor in postmenopausal women

Authors: Sezer Ozer, K.; Erenus, M.; Yoldemir, T.

Source: Climacteric, Volume 12, Number 1, February 2009 , pp. 66-71(6)

Publisher: Informa Healthcare

Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeys

Authors: Hofling, M.; Ma, L.; Sahlin, L.; Haglund, C.; Nordling, S.; von Schoultz, B.; Cline, J. M.

Source: Climacteric, Volume 12, Number 1, February 2009 , pp. 72-79(8)

Publisher: Informa Healthcare

Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women

Authors: Christodoulakos, G. E.; Lambrinoudaki, I. V.; Creatsa, M. G.; Economou, E. V.; Siasou, Z.; Panoulis, C. P.; Kalligerou, I.; Papadias, C.

Source: Climacteric, Volume 11, Number 2, 2008 , pp. 155-165(11)

Publisher: Informa Healthcare